Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Claudio Borghi & Francesca Santi. (2012) Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence. Patient Preference and Adherence 6, pages 449-455.
Read now
Read now
Jean-Jacques Mourad, Sylvain Le Jeune, Anthony Pirollo, Clarisse Mourad, Yann Gaudouen & Marilucy Lopez-Sublet. (2010) Combinations of inhibitors of the renin–angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine. Current Medical Research and Opinion 26:9, pages 2263-2276.
Read now
Read now
Peter Bramlage. (2009) Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension. Vascular Health and Risk Management 5, pages 213-224.
Read now
Read now
Steen Neldam & Colin Edwards. (2009) Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication. Expert Opinion on Pharmacotherapy 10:3, pages 345-352.
Read now
Read now
Menno T Pruijm, Marc P Maillard & Michel Burnier. (2008) Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine. Vascular Health and Risk Management 4:6, pages 1159-1166.
Read now
Read now
. (2007) 2007 ESH‐ESC Guidelines for the management of arterial hypertension. Blood Pressure 16:3, pages 135-232.
Read now
Read now
Articles from other publishers (60)
Trias Mahmudiono, Saade Abdalkareem Jasim, Yasir Salam Karim, Dmitry Olegovich Bokov, Walid Kamal Abdelbasset, Kholmurod S. Akhmedov, Ghulam Yasin, Lakshmi Thangavelu, Yasser Fakri Mustafa, Shehla Shoukat, Mazin A.A. Najm & Mohammad Amraei. (2022) The effect of flaxseed oil consumtion on blood pressure among patients with metabolic syndrome and related disorders: A systematic review and meta‐analysis of randomized clinical trials. Phytotherapy Research 36:10, pages 3766-3773.
Crossref
Crossref
Mark C van der Wel, Marion Biermans, Reinier Akkermans, Jacques WM Lenders, Chris van Weel & Jaap Deinum. (2018) Patient characteristics do not predict the individual response to antihypertensive medication: a cross-over trial. Family Practice 35:1, pages 67-73.
Crossref
Crossref
Izabella Uchmanowicz, Beata Jankowska-Polańska, Anna Chudiak, Anna Szymańska-Chabowska & Grzegorz Mazur. (2016) Psychometric evaluation of the Polish adaptation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. BMC Cardiovascular Disorders 16:1.
Crossref
Crossref
Young-Ran Kim, Tae-Yong Lee & Chang-Soo Park. (2016) A Study on the Relationship between Individual Patient Behavior, Medical Care Level and Therapeutic Compliance: Community Health Survey. Journal of the Korea Academia-Industrial cooperation Society 17:5, pages 104-115.
Crossref
Crossref
Winson Y. Cheung, Edward Chia-Cheng Lai, Jenny Y. Ruan, Jennifer T. Chang & Soko Setoguchi. (2015) Comparative adherence to oral hormonal agents in older women with breast cancer. Breast Cancer Research and Treatment 152:2, pages 419-427.
Crossref
Crossref
Scott A. Baggarly, Robert J. Kemp, Xiaojun Wang & A. Dale Magoun. (2014) Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population. Research in Social and Administrative Pharmacy 10:6, pages e99-e112.
Crossref
Crossref
Roland E. Schmieder, Massimo Volpe, Bernard Waeber & Luis M. Ruilope. (2014) A guide for easy- and difficult-to-treat hypertension. International Journal of Cardiology 172:1, pages 17-22.
Crossref
Crossref
C. Kleinclauss & A. Penfornis. (2014) Compliance nella pratica medica e corrente. EMC - AKOS - Trattato di Medicina 16:1, pages 1-6.
Crossref
Crossref
Xing Liu, Xinyao Liu, Wei Huang, Sunnar Leo, Ying Li, Meilin Liu & Hong Yuan. (2014) Evening -Versus Morning- Dosing Drug Therapy for Chronic Kidney Disease Patients with Hypertension: A Systematic Review. Kidney and Blood Pressure Research 39:5, pages 427-440.
Crossref
Crossref
Bernard Waeber & François Feihl. (2013) Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy. EuroIntervention 9:R, pages R29-R34.
Crossref
Crossref
Rainer Düsing, Patrick Brunel, InYoung Baek & Fabio Baschiera. (2012) Sustained Blood Pressure–Lowering Effect of Aliskiren Compared With Telmisartan After a Single Missed Dose. The Journal of Clinical Hypertension 15:1, pages 41-47.
Crossref
Crossref
Rainer Düsing, Patrick Brunel, InYoung Baek & Fabio Baschiera. (2012) Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan. Journal of Hypertension 30:5, pages 1029-1040.
Crossref
Crossref
Ping Zhao, Ping Xu, Chaomin Wan & Zhengrong Wang. (2011) Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database of Systematic Reviews 2011:11.
Crossref
Crossref
Yusuke Ohya & Atsushi Sakima. (2011) 2. Patient Adherence and Fixed Combination of Antihypertensive Drugs.. Nihon Naika Gakkai Zasshi 100:2, pages 426-431.
Crossref
Crossref
A. Lowy, V. C. Munk, S. H. Ong, M. Burnier, B. Vrijens, E. P. Tousset & J. Urquhart. (2011) Effects on blood pressure and cardiovascular risk of variations in patients’ adherence to prescribed antihypertensive drugs: role of duration of drug action. International Journal of Clinical Practice 65:1, pages 41-53.
Crossref
Crossref
Chern-En Chiang, Tzung-Dau Wang, Yi-Heng Li, Tsung-Hsien Lin, Kuo-Liong Chien, Hung-I Yeh, Kou-Gi Shyu, Wei-Chuen Tsai, Ting-Hsing Chao, Juey-Jen Hwang, Fu-Tien Chiang & Jyh-Hong Chen. (2010) 2010 Guidelines of the Taiwan Society of Cardiology for the Management of Hypertension. Journal of the Formosan Medical Association 109:10, pages 740-773.
Crossref
Crossref
Bernard Waeber & Friedrich Stiefel. (2010) Impact of depression on drug intake in hypertensive patients. Journal of Hypertension 28:9, pages 1804-1805.
Crossref
Crossref
Giovanni Corrao, Andrea Parodi, Antonella Zambon, Franca Heiman, Alessandro Filippi, Claudio Cricelli, Luca Merlino & Giuseppe Mancia. (2010) Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. Journal of Hypertension 28:7, pages 1584-1590.
Crossref
Crossref
Dean G. Cruess, A. Russell Localio, Alec B. Platt, Colleen M. Brensinger, Jason D. Christie, Robert Gross, Catherine S. Parker, Maureen Price, Joshua P. Metlay, Abigail Cohen, Craig W. Newcomb, Brian L. Strom & Stephen E. Kimmel. (2009) Patient Attitudinal and Behavioral Factors Associated with Warfarin Non-adherence at Outpatient Anticoagulation Clinics. International Journal of Behavioral Medicine 17:1, pages 33-42.
Crossref
Crossref
Kazeem B Yusuff & Abdrahman Alabi. (2007) Assessing patient adherence to anti-hypertensive drug therapy: can a structured pharmacist-conducted interview separate the wheat from the chaff?. International Journal of Pharmacy Practice 15:4, pages 295-300.
Crossref
Crossref
José Ma Lobos Bejarano, Miguel Angel Royo-Bordonada, Carlos Brotons, Luís Álvarez-Sala, Pedro Armario, Antonio Maiques, Dídac Mauricio, Susana Sans, Fernando Villar, Angel Lizcano, Antonio Gil-Núñez, Fernando de Álvaro, Pedro Conthe, Emilio Luengo, Alfonso del Río, Olga Cortés, Ana de Santiago, Miguel A. Vargas, Mercedes Martínez & Vicenta Lizarbe. (2009) Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008. Atención Primaria 41:8, pages 463.e1-463.e24.
Crossref
Crossref
J.M. Lobos, M. Ángel Royo-Bordonada, C. Brotons, L. Álvarez-Sala, P. Armario, A. Maiques, D. Mauricio, S. Sans, F. Villar, Á. Lizcano, A. Gil-Núñez, F. de Álvaro, P. Conthe, E. Luengo, A. del Río, O. Cortés, A. de Santiago, M.A. Vargas, M. Martínez & V. Lizarbe. (2009) Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008. Hipertensión y Riesgo Vascular 26:4, pages 157-180.
Crossref
Crossref
José M. Lobos, Miguel Ángel Royo-Bordonada, Carlos Brotons, Luis Álvarez-Sala, Pedro Armario, Antonio Maiques, Dídac Mauricio, Susana Sans, Fernando Villar, Ángel Lizcano, Antonio Gil-Núñez, Fernando de Álvaro, Pedro Conthe, Emilio Luengo, Alfonso del Río, Olga Cortés, Ana de Santiago, Miguel A. Vargas, Mercedes Martínez & Vicenta Lizarbe. (2009) Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008. Clínica e Investigación en Arteriosclerosis 21:3, pages 124-150.
Crossref
Crossref
J.M. Lobos, M.Á. Royo-Bordonada, C. Brotons, L. Álvarez-Sala, P. Armario, A. Maiques, D. Mauricio, S. Sans, F. Villar, Á. Lizcano, A. Gil-Núñez, F. de Álvaro, P. Conthe, E. Luengo, A. del Río, O. Cortés, A. de Santiago, M.A. Varga, M. Martínez & V. Lizarbe. (2009) Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008. Revista Clínica Española 209:6, pages 279-302.
Crossref
Crossref
Ramiro A Sanchez, Miryam Ayala, Hugo Baglivo, Carlos Velazquez, Guillermo Burlando, Oswaldo Kohlmann, Jorge Jimenez, Patricio López Jaramillo, Ayrton Brandao, Gloria Valdes, Luis Alcocer, Mario Bendersky, Agustín José Ramirez & Alberto Zanchetti. (2009) Latin American guidelines on hypertension*. Journal of Hypertension 27:5, pages 905-922.
Crossref
Crossref
Isabelle Mulazzi, Jean Pierre Cambou, Xavier Girerd, Robert Nicodeme, Bernard Chamontin & Jacques Amar. (2009) Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice. Journal of the American Society of Hypertension 3:3, pages 221-227.
Crossref
Crossref
Rainer Düsing, Renate Handrock, Sven Klebs, Eric Tousset & Bernard Vrijens. (2009) Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. Journal of Hypertension 27:4, pages 894-901.
Crossref
Crossref
Steven G. Chrysant, Joel M. Neutel, Keith C. Ferdinand & for the Inclusive investigators. (2009) Irbesartan/Hydrochlorothiazide for the Treatment of Isolated Systolic Hypertension:A Subgroup Analysis of the INCLUSIVE Trial. Journal of the National Medical Association 101:4, pages 300-307.
Crossref
Crossref
J.M. Lobos, M.Á. Royo-Bordonada, C. Brotons, L. Álvarez-Sala, P. Armario, A. Maiques, D. Mauricio, S. Sans, F. Villar, Á. Lizcano, A. Gil-Núñez, F. de Álvaro, P. Conthe, E. Luengo, A. del Río, O. Cortés-Rico, A. de Santiago, M.A. Vargas, M. Martínez & V. Lizarbe. (2009) Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008. SEMERGEN - Medicina de Familia 35:2, pages 66-85.
Crossref
Crossref
Jin-Wook ChungHae-Young Lee, Cheol-Ho KimIn-Whan SeungYung-Woo ShinMyung-Ho JeongMyeong-Chan ChoByung-Hee Oh. (2009) Losartan/Hydrochlorothiazide Fixed Combination Versus Amlodipine Monotherapy in Korean Patients With Mild to Moderate Hypertension. Korean Circulation Journal 39:4, pages 151.
Crossref
Crossref
Michael H. Crawford. (2012) Combination Therapy as First-Line Treatment for Hypertension. American Journal of Cardiovascular Drugs 9:1, pages 1-6.
Crossref
Crossref
George S Stergiou & Efthimia G Nasothimiou. (2008) Does dosing antihypertensive drugs at night alter renal or cardiovascular outcome: do we have the evidence?. Current Opinion in Nephrology and Hypertension 17:5, pages 464-469.
Crossref
Crossref
Antoinette Schoenthaler & Gbenga Ogedegbe. (2008) Patients’ Perceptions of Electronic Monitoring Devices Affect Medication Adherence in Hypertensive African Americans. Annals of Pharmacotherapy 42:5, pages 647-652.
Crossref
Crossref
J M Neutel, S S Franklin, P Lapuerta, A Bhaumik & A Ptaszynska. (2007) A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension. Journal of Human Hypertension 22:4, pages 266-274.
Crossref
Crossref
Boris Gojanovic, François Feihl, Lucas Liaudet & Bernard Waeber. (2008) Review: Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. Journal of the Renin-Angiotensin-Aldosterone System 9:1, pages 1-9.
Crossref
Crossref
Luc M Van Bortel, Francesco Fici & Flavio Mascagni. (2008) Efficacy and Tolerability of Nebivolol Compared with Other Antihypertensive Drugs. American Journal of Cardiovascular Drugs 8:1, pages 35-44.
Crossref
Crossref
. (2008) Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: versión resumida. Revista Española de Cardiología 61:1, pages 82.e1-82.e49.
Crossref
Crossref
William C. Cushman, Joel M. Neutel, Elijah Saunders, George L. Bakris, Keith C. Ferdinand, Elizabeth O. Ofili, James R. Sowers, Robert Madder & Michael A. Weber. (2008) Efficacy and Safety of Fixed Combinations of Irbesartan/Hydrochlorothiazide in Older vs Younger Patients With Hypertension Uncontrolled With Monotherapy. The American Journal of Geriatric Cardiology 17:1, pages 27-36.
Crossref
Crossref
G Bakris, M Hill, G Mancia, K Steyn, H R Black, T Pickering, S De Geest, L Ruilope, T D Giles, T Morgan, S Kjeldsen, E L Schiffrin, A Coenen, P Mulrow, A Loh & G Mensah. (2007) Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. Journal of Human Hypertension 22:1, pages 63-70.
Crossref
Crossref
. (2007) Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007. Revista Española de Cardiología 60:9, pages 968.e1-968.e94.
Crossref
Crossref
. (2017) Chapter 1: Introduction. European Journal of Cardiovascular Prevention & Rehabilitation 14:2_suppl, pages S2-S113.
Crossref
Crossref
Ian GrahamDan AtarKnut Borch-JohnsenGudrun BoysenGunilla BurellRenata CifkovaJean DallongevilleGuy De BackerShah EbrahimBjørn GjelsvikChristoph Herrmann-LingenArno HoesSteve HumphriesMike KnaptonJoep PerkSilvia G. PrioriKalevi PyoralaZeljko ReinerLuis RuilopeSusana Sans-MenendezWilma Scholte Op ReimerPeter WeissbergDavid WoodJohn YarnellJose Luis Zamorano. (2017) Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). European Journal of Cardiovascular Prevention & Rehabilitation 14:2_suppl, pages E1-E40.
Crossref
Crossref
Ian Graham. (2007) European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Atherosclerosis 194:1, pages 1-45.
Crossref
Crossref
I P Kolos, T V Martynyuk & I E Chazova. (2007) Fiksirovannaya kombinatsiya perindoprila i indapamida u patsientov s arterial'noy gipertenziey v usloviyakh real'noy klinicheskoy praktiki. Systemic Hypertension 4:2, pages 21-26.
Crossref
Crossref
K Brixius, M Middeke, A Lichtenthal, E Jahn & R H G Schwinger. (2007) NITRIC OXIDE, ERECTILE DYSFUNCTION AND BETA-BLOCKER TREATMENT (MR NOED STUDY): BENEFIT OF NEBIVOLOL VERSUS METOPROLOL IN HYPERTENSIVE MEN. Clinical and Experimental Pharmacology and Physiology 34:4, pages 327-331.
Crossref
Crossref
Bernard Waeber & Michel Burnier. (2006) Differential persistence with initial antihypertensive therapies: a clue for understanding the needs of hypertensive patients. Journal of Hypertension 24:6, pages 1021-1022.
Crossref
Crossref
Paolo Palatini. (2007) Combination Therapy in the Management of Hypertension: Focus on Angiotensin Receptor Blockers Combined With Diuretics. The Journal of Clinical Hypertension 7:2, pages 96-101.
Crossref
Crossref
Bernard Waeber. (2004) What has been learned from electronic monitoring of compliance with antihypertensive medications?. Journal of Hypertension 22:10, pages 1857-1858.
Crossref
Crossref
A Degl'Innocenti, D Elmfeldt, A Hofman, H Lithell, B Olofsson, I Skoog, P Trenkwalder, A Zanchetti & I Wiklund. (2004) Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE). Journal of Human Hypertension 18:4, pages 239-245.
Crossref
Crossref
C Ingino, C Farsang, A Laucevicius & M Bergovec. (2003) An Open-Label Study Investigating the Efficacy and Safety of 12–96 Weeks of Telmisartan Treatment in Patients with Hypertension. Journal of International Medical Research 31:6, pages 561-574.
Crossref
Crossref
Tanya M. Romain, Rosalie P. Patel, Andrea M. Heaberlin & Barbara J. Zarowitz. (2012) Assessment of Factors Influencing Blood Pressure Control in a Managed Care Population. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23:8, pages 1060-1070.
Crossref
Crossref
Bernard Waeber. (2003) Very-low-dose combination: a first-line choice for the treatment of hypertension?. Journal of Hypertension 21, pages S3-S10.
Crossref
Crossref
Junko Okuno, Shigeo Tomura & Hisako Yanagi. (2002) Treated hypertensives with good medication compliance are still in a state of uncontrolled blood pressure in the Japanese elderly. Environmental Health and Preventive Medicine 7:5, pages 193-198.
Crossref
Crossref
Y Lacourcière. (2016) A New Fixed-Dose Combination for Added Blood Pressure Control: Telmisartan Plus Hydrochlorothiazide. Journal of International Medical Research 30:4, pages 366-379.
Crossref
Crossref
Bernard Waeber. (2002) Fixed low-dose combination therapy for hypertension. Current Hypertension Reports 4:4, pages 298-306.
Crossref
Crossref
CM Langman, AC Lyons & GYH Lip. (2002) ‘You cannot be serious!’ Compliance and antihypertensive regimens. International Journal of Clinical Practice 56:3, pages 164-166.
Crossref
Crossref
Joachim Stangier, Chung-An P. F. Su, Pauline N. M. van Heiningen, Thomas Meinicke, Jan J. van Lier, Henrieke de Bruin, Wim J. Tamminga & Jan H. G. Jonkman. (2001) Inhibitory Effect of Telmisartan on the Blood Pressure Response to Angiotensin II Challenge. Journal of Cardiovascular Pharmacology 38:5, pages 672-685.
Crossref
Crossref
Michel Burnier, Marie Paule Schneider, Arnaud Chioléro, Claire Lise Fallab Stubi & Hans R. Brunner. (2001) Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. Journal of Hypertension 19:2, pages 335-341.
Crossref
Crossref
Michael StimpelMichael Stimpel. 2001. Arterielle Hypertonie. Arterielle Hypertonie
221
233
.
Teresa M. Zyczynski & Karin S. Coyne. (2000) Hypertension and current issues in compliance and patient outcomes. Current Hypertension Reports 2:6, pages 510-514.
Crossref
Crossref